Mary Rinella, MD

Determining Cirrhosis Status in Candidates for Resmetirom.
Determining Cirrhosis Status in Candidates for Resmetirom. Clin Gastroenterol Hepatol. 2025 May 10.
PMID: 40354924

Efruxifermin in Compensated Liver Cirrhosis Caused by MASH.
Efruxifermin in Compensated Liver Cirrhosis Caused by MASH. N Engl J Med. 2025 May 09.
PMID: 40341827

Awareness of metabolic dysfunction-associated steatotic liver disease (MASLD) in 4 major cities in the United States.
Awareness of metabolic dysfunction-associated steatotic liver disease (MASLD) in 4 major cities in the United States. Hepatol Commun. 2025 May 01; 9(5).
PMID: 40331869

An Expert Consensus Delphi Panel in MetALD: Opportunities and Challenges in Clinical Practice.
An Expert Consensus Delphi Panel in MetALD: Opportunities and Challenges in Clinical Practice. Clin Gastroenterol Hepatol. 2025 Apr 30.
PMID: 40315973

Phase 3 Trial of Semaglutide in Metabolic Dysfunction-Associated Steatohepatitis.
Phase 3 Trial of Semaglutide in Metabolic Dysfunction-Associated Steatohepatitis. N Engl J Med. 2025 Apr 30.
PMID: 40305708

Moving beyond the liver - proteomics as a molecular footprint of systemic damage in metabolic dysfunction-associated steatotic liver disease.
Moving beyond the liver - proteomics as a molecular footprint of systemic damage in metabolic dysfunction-associated steatotic liver disease. Hepatology. 2025 Apr 29.
PMID: 40300080

Erratum: Late breaking abstracts.
Erratum: Late breaking abstracts. Hepatology. 2025 Jun 01; 81(6):E178.
PMID: 40258120

Emerging Therapies and Real-World Application of Metabolic Dysfunction-Associated Steatotic Liver Disease Treatment.
Emerging Therapies and Real-World Application of Metabolic Dysfunction-Associated Steatotic Liver Disease Treatment. Clin Mol Hepatol. 2025 Apr 02.
PMID: 40170239

Low HDL cholesterol levels in women and hypertriglyceridemia in men: predictors of MASLD onset in individuals without steatosis.
Low HDL cholesterol levels in women and hypertriglyceridemia in men: predictors of MASLD onset in individuals without steatosis. J Gastroenterol. 2025 Mar 18.
PMID: 40097845

Liver Transplantation: Changing Indications and Changing Candidates.
Liver Transplantation: Changing Indications and Changing Candidates. Clin Liver Dis. 2025 May; 29(2):157-163.
PMID: 40287264

View All Publications